Swiss Go Trial Group
Clinical trials sponsored by Swiss Go Trial Group, explained in plain language.
-
Could a common breast cancer drug keep ovarian cancer at bay?
Disease control Recruiting nowThis study tests whether adding letrozole, a hormone therapy used in breast cancer, to standard maintenance treatment can delay the return of ovarian cancer. About 540 women with estrogen-receptor-positive ovarian cancer who have completed initial surgery and chemotherapy will re…
Phase: PHASE3 • Sponsor: Swiss GO Trial Group • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Can a tumor 'Fingerprint' improve ovarian cancer care? new study aims to find out
Knowledge-focused Recruiting nowThis study is testing whether giving doctors extra, detailed information about a patient's tumor helps them choose a better treatment plan for advanced ovarian cancer. About 60 newly diagnosed patients will be split into two groups: one gets standard care, and the other gets a pe…
Phase: NA • Sponsor: Swiss GO Trial Group • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Ultrasound clues to adenomyosis pain and bleeding explored in 1,000 women
Knowledge-focused Recruiting nowThis study looks at how certain ultrasound findings in the uterus relate to symptoms of adenomyosis, a condition that can cause pain and heavy bleeding. Researchers will enroll 1,000 women before or around menopause who are getting a routine gynecological ultrasound. Participants…
Sponsor: Swiss GO Trial Group • Aim: Knowledge-focused
Last updated May 04, 2026 16:20 UTC